Methscopolamine Bromide and Moxetumomab Pasudotox-tdfk
Determining the interaction of Methscopolamine Bromide and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methscopolamine
Brand name: Pamine, Pamine Forte
Synonyms: Methscopolamine
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methscopolamine Bromide-Moxetumomab pasudotox-tdfk Intravenous
- Methscopolamine Bromide-Moxifloxacin
- Methscopolamine Bromide-Moxifloxacin (Systemic)
- Methscopolamine Bromide-Moxifloxacin Hydrochloride
- Methscopolamine Bromide-Moxifloxacin Injection
- Methscopolamine Bromide-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Methsuximide
- Moxetumomab Pasudotox-tdfk-Methyclothiazide
- Moxetumomab Pasudotox-tdfk-Methyl Aminolevulinate
- Moxetumomab Pasudotox-tdfk-Methyl aminolevulinate topical
- Moxetumomab Pasudotox-tdfk-Methyl aminolevulinate Topical application
- Moxetumomab Pasudotox-tdfk-Methyl B-12 vitamin B12